U.S. vaccine panel recommends GSK's Rotarix

06/26/2008 | Bloomberg

The U.S. Advisory Committee on Immunization Practices on Wednesday approved the inclusion of Rotarix, GlaxoSmithKline PLC's rotavirus vaccine, in the list of recommended childhood immunizations. The vaccine, co-developed with Avant Immunotherapeutics, is expected to compete against Merck & Co.'s RotaTeq.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Medtronic
Fridley, MN
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC